Cisplatin 100 mg/100mL (Cisplatin INJECTION, SOLUTION) 100 mg/100mL

Cisplatin 100 mg/100mL is a chemotherapy medication used to treat various types of cancer. This intravenous solution is manufactured by Teva Parenteral Medicines, Inc. in the USA.

Strength

100 mg/100mL

Pack Size

1 VIAL, MULTI-DOSE in 1 CARTON (0703-5748-11) / 100 mL in 1 VIAL, MULTI-DOSE

Manufacturer / TM Owner

Teva Parenteral Medicines, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cisplatin 100 mg/100mL is primarily used in cancer treatment, often as part of a combination therapy. It works by interfering with the growth and spread of cancer cells. The medication is administered intravenously and is commonly prescribed for what is cisplatin used for, including ovarian, bladder, and lung cancers.

Side Effects

Common effects of cisplatin may include nausea, vomiting, and fatigue. Some individuals may experience hair loss or changes in taste. These effects can vary in severity and duration. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Cisplatin should be handled with care, as it is a potent medication. It is important to follow proper administration guidelines to avoid contamination. Pregnant women and individuals with certain medical conditions should exercise caution. Always store the medication as directed.

Avoid Interactions

Cisplatin may interact with other medications, including certain antibiotics and diuretics. It is important to inform your healthcare provider about all medications you are taking. Alcohol and other substances may also interact with cisplatin, so it is best to avoid them unless advised otherwise.

Frequently Asked Questions

Cisplatin is used in the treatment of various types of cancer, including ovarian, bladder, and lung cancers.

Cisplatin is administered intravenously, typically by a healthcare professional in a clinical setting.

Common side effects may include nausea, vomiting, fatigue, hair loss, and changes in taste.

Pregnant women should exercise caution and consult their healthcare provider before using cisplatin.

Cisplatin should be stored as directed by the healthcare provider or pharmacist, typically in a cool, dry place.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.